| UniProt ID | AZI2_HUMAN | |
|---|---|---|
| UniProt AC | Q9H6S1 | |
| Protein Name | 5-azacytidine-induced protein 2 | |
| Gene Name | AZI2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 392 | |
| Subcellular Localization | Cytoplasm . | |
| Protein Description | Adapter protein which binds TBK1 and IKBKE playing a role in antiviral innate immunity. Activates serine/threonine-protein kinase TBK1 and facilitates its oligomerization. Enhances the phosphorylation of NF-kappa-B p65 subunit RELA by TBK1. Promotes TBK1-induced as well as TNF-alpha or PMA-induced activation of NF-kappa-B. Participates in IFNB promoter activation via TICAM1.. | |
| Protein Sequence | MDALVEDDICILNHEKAHKRDTVTPVSIYSGDESVASHFALVTAYEDIKKRLKDSEKENSLLKKRIRFLEEKLIARFEEETSSVGREQVNKAYHAYREVCIDRDNLKSKLDKMNKDNSESLKVLNEQLQSKEVELLQLRTEVETQQVMRNLNPPSSNWEVEKLSCDLKIHGLEQELELMRKECSDLKIELQKAKQTDPYQEDNLKSRDLQKLSISSDNMQHAYWELKREMSNLHLVTQVQAELLRKLKTSTAIKKACAPVGCSEDLGRDSTKLHLMNFTATYTRHPPLLPNGKALCHTTSSPLPGDVKVLSEKAILQSWTDNERSIPNDGTCFQEHSSYGRNSLEDNSWVFPSPPKSSETAFGETKTKTLPLPNLPPLHYLDQHNQNCLYKN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 19 | Ubiquitination | LNHEKAHKRDTVTPV CCCHHHCCCCCCCCE | 57.75 | 29967540 | |
| 24 | Phosphorylation | AHKRDTVTPVSIYSG HCCCCCCCCEEEECC | 21.77 | 19060867 | |
| 50 | Ubiquitination | TAYEDIKKRLKDSEK HHHHHHHHHCCCHHH | 64.40 | 29967540 | |
| 60 | Phosphorylation | KDSEKENSLLKKRIR CCHHHHHHHHHHHHH | 35.85 | 24719451 | |
| 63 | Ubiquitination | EKENSLLKKRIRFLE HHHHHHHHHHHHHHH | 45.35 | 24816145 | |
| 66 | Ubiquitination | NSLLKKRIRFLEEKL HHHHHHHHHHHHHHH | 5.12 | 24816145 | |
| 80 | Ubiquitination | LIARFEEETSSVGRE HHHHHHHHHCCCCHH | 46.95 | 29967540 | |
| 81 | Phosphorylation | IARFEEETSSVGREQ HHHHHHHHCCCCHHH | 29.58 | 28857561 | |
| 82 | Phosphorylation | ARFEEETSSVGREQV HHHHHHHCCCCHHHH | 26.72 | 18691976 | |
| 83 | Phosphorylation | RFEEETSSVGREQVN HHHHHHCCCCHHHHH | 35.69 | 28857561 | |
| 91 | Ubiquitination | VGREQVNKAYHAYRE CCHHHHHHHHHHHHH | 52.01 | 29967540 | |
| 93 | Ubiquitination | REQVNKAYHAYREVC HHHHHHHHHHHHHHH | 6.65 | 22817900 | |
| 118 | Phosphorylation | DKMNKDNSESLKVLN HHHCCCCHHHHHHHH | 38.40 | 30619164 | |
| 120 | Phosphorylation | MNKDNSESLKVLNEQ HCCCCHHHHHHHHHH | 33.05 | 28857561 | |
| 122 | Ubiquitination | KDNSESLKVLNEQLQ CCCHHHHHHHHHHHH | 54.69 | 29967540 | |
| 130 | Phosphorylation | VLNEQLQSKEVELLQ HHHHHHHHCHHHHHH | 39.10 | 27499020 | |
| 131 | Ubiquitination | LNEQLQSKEVELLQL HHHHHHHCHHHHHHH | 53.47 | 29967540 | |
| 140 | Phosphorylation | VELLQLRTEVETQQV HHHHHHHHHHHHHHH | 53.64 | - | |
| 143 | Ubiquitination | LQLRTEVETQQVMRN HHHHHHHHHHHHHHH | 34.37 | 29967540 | |
| 144 | Phosphorylation | QLRTEVETQQVMRNL HHHHHHHHHHHHHHC | 29.49 | - | |
| 148 | Sulfoxidation | EVETQQVMRNLNPPS HHHHHHHHHHCCCCC | 1.72 | 21406390 | |
| 155 | Phosphorylation | MRNLNPPSSNWEVEK HHHCCCCCCCCCCEE | 37.24 | 28348404 | |
| 156 | Phosphorylation | RNLNPPSSNWEVEKL HHCCCCCCCCCCEEH | 52.30 | 28348404 | |
| 162 | Ubiquitination | SSNWEVEKLSCDLKI CCCCCCEEHHHCEEE | 51.37 | 29967540 | |
| 164 | Phosphorylation | NWEVEKLSCDLKIHG CCCCEEHHHCEEECC | 19.36 | - | |
| 181 | Ubiquitination | QELELMRKECSDLKI HHHHHHHHHHHHHHH | 49.46 | 29967540 | |
| 192 | Ubiquitination | DLKIELQKAKQTDPY HHHHHHHHHHCCCCC | 70.90 | 29967540 | |
| 194 | Ubiquitination | KIELQKAKQTDPYQE HHHHHHHHCCCCCCC | 61.85 | - | |
| 196 | Ubiquitination | ELQKAKQTDPYQEDN HHHHHHCCCCCCCCC | 37.93 | 22817900 | |
| 201 | Ubiquitination | KQTDPYQEDNLKSRD HCCCCCCCCCCCCCC | 42.92 | 22817900 | |
| 205 (in isoform 1) | Ubiquitination | - | 50.10 | 21906983 | |
| 205 | Ubiquitination | PYQEDNLKSRDLQKL CCCCCCCCCCCHHHH | 50.10 | 21906983 | |
| 205 (in isoform 3) | Ubiquitination | - | 50.10 | 21906983 | |
| 208 | Ubiquitination | EDNLKSRDLQKLSIS CCCCCCCCHHHHCCC | 61.62 | 22817900 | |
| 213 | Phosphorylation | SRDLQKLSISSDNMQ CCCHHHHCCCCCHHH | 27.71 | 24275569 | |
| 244 | Ubiquitination | TQVQAELLRKLKTST HHHHHHHHHHHCCCH | 3.23 | 29967540 | |
| 249 | Phosphorylation | ELLRKLKTSTAIKKA HHHHHHCCCHHHHHH | 41.57 | - | |
| 250 | Phosphorylation | LLRKLKTSTAIKKAC HHHHHCCCHHHHHHC | 17.79 | - | |
| 251 | Phosphorylation | LRKLKTSTAIKKACA HHHHCCCHHHHHHCC | 37.32 | - | |
| 255 | Ubiquitination | KTSTAIKKACAPVGC CCCHHHHHHCCCCCC | 42.45 | 29967540 | |
| 263 | Phosphorylation | ACAPVGCSEDLGRDS HCCCCCCCCHHCCCC | 28.37 | - | |
| 270 | Phosphorylation | SEDLGRDSTKLHLMN CCHHCCCCCEEEEEE | 26.53 | 27251275 | |
| 293 | Ubiquitination | PPLLPNGKALCHTTS CCCCCCCCEECCCCC | 44.84 | 29967540 | |
| 298 | Phosphorylation | NGKALCHTTSSPLPG CCCEECCCCCCCCCC | 27.63 | 28450419 | |
| 299 | Phosphorylation | GKALCHTTSSPLPGD CCEECCCCCCCCCCC | 11.98 | 25159151 | |
| 300 | Phosphorylation | KALCHTTSSPLPGDV CEECCCCCCCCCCCC | 30.98 | 25159151 | |
| 301 | Phosphorylation | ALCHTTSSPLPGDVK EECCCCCCCCCCCCE | 28.50 | 25159151 | |
| 308 | Ubiquitination | SPLPGDVKVLSEKAI CCCCCCCEEECHHHH | 42.05 | 22817900 | |
| 311 | Phosphorylation | PGDVKVLSEKAILQS CCCCEEECHHHHHHH | 39.79 | 28634298 | |
| 311 | Ubiquitination | PGDVKVLSEKAILQS CCCCEEECHHHHHHH | 39.79 | 22817900 | |
| 313 | Ubiquitination | DVKVLSEKAILQSWT CCEEECHHHHHHHCC | 37.03 | 22817900 | |
| 313 (in isoform 1) | Ubiquitination | - | 37.03 | 21906983 | |
| 316 | Ubiquitination | VLSEKAILQSWTDNE EECHHHHHHHCCCCC | 3.84 | 22817900 | |
| 318 | Phosphorylation | SEKAILQSWTDNERS CHHHHHHHCCCCCCC | 28.62 | 23927012 | |
| 320 | Phosphorylation | KAILQSWTDNERSIP HHHHHHCCCCCCCCC | 33.91 | 28450419 | |
| 325 | Phosphorylation | SWTDNERSIPNDGTC HCCCCCCCCCCCCCC | 35.90 | 27251275 | |
| 331 | Phosphorylation | RSIPNDGTCFQEHSS CCCCCCCCCCCCCCC | 17.01 | 28348404 | |
| 337 | Phosphorylation | GTCFQEHSSYGRNSL CCCCCCCCCCCCCCC | 25.22 | 28348404 | |
| 338 | Phosphorylation | TCFQEHSSYGRNSLE CCCCCCCCCCCCCCC | 33.25 | 27251275 | |
| 339 | Phosphorylation | CFQEHSSYGRNSLED CCCCCCCCCCCCCCC | 24.10 | 28348404 | |
| 343 | Phosphorylation | HSSYGRNSLEDNSWV CCCCCCCCCCCCCEE | 31.60 | 25850435 | |
| 348 | Phosphorylation | RNSLEDNSWVFPSPP CCCCCCCCEECCCCC | 36.62 | 30266825 | |
| 353 | Phosphorylation | DNSWVFPSPPKSSET CCCEECCCCCCCCCC | 42.23 | 30266825 | |
| 356 | Ubiquitination | WVFPSPPKSSETAFG EECCCCCCCCCCCCC | 70.74 | 29967540 | |
| 357 | Phosphorylation | VFPSPPKSSETAFGE ECCCCCCCCCCCCCC | 38.90 | 25159151 | |
| 358 | Phosphorylation | FPSPPKSSETAFGET CCCCCCCCCCCCCCC | 45.13 | 26852163 | |
| 360 | Phosphorylation | SPPKSSETAFGETKT CCCCCCCCCCCCCCC | 29.27 | 26852163 | |
| 365 | Phosphorylation | SETAFGETKTKTLPL CCCCCCCCCCEEECC | 44.38 | 26852163 | |
| 366 | Ubiquitination | ETAFGETKTKTLPLP CCCCCCCCCEEECCC | 43.66 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AZI2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AZI2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AZI2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MIB1_HUMAN | MIB1 | physical | 21903422 | |
| APBA3_HUMAN | APBA3 | physical | 21903422 | |
| CACO2_HUMAN | CALCOCO2 | physical | 21903422 | |
| IKKE_HUMAN | IKBKE | physical | 21903422 | |
| PAPD1_HUMAN | MTPAP | physical | 21903422 | |
| N4BP1_HUMAN | N4BP1 | physical | 21903422 | |
| RNF31_HUMAN | RNF31 | physical | 21903422 | |
| TBK1_HUMAN | TBK1 | physical | 21903422 | |
| TRAF3_HUMAN | TRAF3 | physical | 21903422 | |
| TXLNA_HUMAN | TXLNA | physical | 21903422 | |
| TXLNG_HUMAN | TXLNG | physical | 21903422 | |
| TBK1_HUMAN | TBK1 | physical | 14560022 | |
| IKKE_HUMAN | IKBKE | physical | 17568778 | |
| TBK1_HUMAN | TBK1 | physical | 17568778 | |
| TBKB1_HUMAN | TBKBP1 | physical | 17568778 | |
| AZI2_HUMAN | AZI2 | physical | 17568778 | |
| TRI38_HUMAN | TRIM38 | physical | 22539786 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-24; THR-81; SER-82;THR-299; SER-300; SER-318; SER-348; SER-353 AND SER-357, AND MASSSPECTROMETRY. | |